Natarajan Sethuraman
Net worth: 1 M $ as of 31/07/2026
Net worth: 1 M $ as of 31/07/2026
Natarajan Sethuraman currently works at Entrada Therapeutics, Inc., as President-Research & Development from 2024.
Dr. Sethuraman also formerly worked at Merck & Co., Inc., as Executive Director & Head-GlycoFi Site from 2012 to 2016 and Medical Enzymes AG, as Senior Scientist.
Dr. Sethuraman received his graduate degree and doctorate degree from Indian Agricultural Research Institute and undergraduate degree from Tamilnadu Agricultural University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/09/2026 | 214,238 ( 0.55% ) | 1 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2017 |
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Director/Board Member | 01/07/2016 |
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Develops product family based on amino acid depleting enzymes | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Indian Agricultural Research Institute
Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tamilnadu Agricultural University
Tamilnadu Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Develops product family based on amino acid depleting enzymes | Health Services |
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions